Elon Musk, the owner of X, has recently inquired about Vitalik Buterin’s noticeable absence from the social media platform X. This query was prompted by a user’s suggestion that Buterin, the co-founder of Ethereum, should increase his presence on X to boost Ethereum’s visibility.
Buterin’s account on X is still active, boasting over 5.2 million followers. However, his increased activity on Farcaster, a decentralized social network, has raised questions about his engagement strategy.
A user’s post highlighted the need for Buterin to be more present on X, arguing that his preference for Farcaster might not serve Ethereum’s interests well. The user expressed skepticism about Farcaster’s ability to dominate the cultural conversation, stating, “Farcaster isn’t going to win the culture war.”
Ethereum: Buterin Farcaster Communication
Furthermore, the tweet from X read: “If he (Buterin) wants Ethereum to shine, he should engage more on this platform (X), not sequester himself with his chosen peers on an island.” The sentiment is that Buterin’s influence would be greater if he interacted with the larger community on X.
In response to the habits of X users, Buterin admitted in January that he favoured Farcaster. Also, Tyler John, a technology policy grantmaker at Longview, noted that Buterin’s posts on X often attract a flood of sycophants, crypto bots, and followers who overshadow the content with tickers, memes, and excessive praise. Moreover, this has led Buterin to adopt the phrase “srry 4 ratio-ing” in his replies, acknowledging the overwhelming response his posts receive.
However, Buterin’s choice to use Farcaster for most of his communication reflects his desire for a more focused and substantive interaction with his audience, away from the noise and distractions prevalent on X.
Related Reading | Dogecoin Creator’s Surprising Bitcoin Remark Sparks Crypto Frenzy
Furthermore, the author’s views are for reference only and shall not constitute investment advice. Before purchasing, please ensure you fully understand and assess the products and associated risks.
Comments (No)